Keeping it Real: Patient Engagement in Evidence Generation

Explore how AI can revolutionize your daily practice in Medical Affairs. This session will present a Regulatory bodies such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasingly recognising the value of supplementing clinical trial data with real-world evidence to improve understanding of drug performance in the healthcare setting.

Consequently, Pharma companies are increasingly including real-world studies in their evidence

• Understand the opportunities and best practices for involving patient partners in the generation of real-world evidence
• Explore, using case studies, the value of patient engagement in the design, delivery, analysis and communication of real-world studies
• Highlight the importance of Medical Affairs and Health Economics and Outcomes Research (HEOR) professionals in partnering with colleagues from different functions in Pharma to ensure patients are effectively engaged throughout the product lifecycle
• Discuss barriers and propose solutions to optimal patient engagement in real-world studies

Moderator:

Cerise James

Regional Medical Director

Evidence Generation Domain Lead

Panelist:

Dawn Lobban

Co-Founder

Amica Scientific

Panelist:

Susan Thornton

CEO

Cutaneous Lymphoma Foundation

Panelist:

Angela Williams

VP Global HEOR Head

Kyowa Kirin

Panelist:

Bhavik Pandya

Director, Oncology Health Economics

Astellas